Virtual Medicinal Product (VMP) - Debrisoquine 10mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Debrisoquine 10mg tablets | Start Date 07-02-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- C02CC04
- BNF Codes
-
- BNF code 02050300
| Code | Start Date | End Date |
|---|---|---|
| 42208311000001107 | 01-09-2023 | |
| 318724006 | 07-02-2003 | 31-08-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Debrisoquine sulfate | Based on Base Substance | Debrisoquine | 10 mg |
Name
Debrisoquine sulfate
Basis of strength description
Based on Base Substance
BOSS
Debrisoquine
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
Parent Products
-
VTMDebrisoquine
-
VMP(Current) Debrisoquine 10mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 100 tablet |